Alterations in Choline Metabolism in Non-Obese Individuals with Insulin Resistance and Type 2 Diabetes Mellitus

被引:1
|
作者
Al-Sulaiti, Haya [1 ,2 ]
Anwardeen, Najeha [2 ]
Bashraheel, Sara S. [3 ]
Naja, Khaled [2 ]
Elrayess, Mohamed A. [2 ,3 ]
机构
[1] Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, QU Hlth, POB 2713, Doha, Qatar
[2] Qatar Univ, Biomed Res Ctr, POB 2713, Doha, Qatar
[3] Qatar Univ, Coll Med, QU Hlth, POB 2713, Doha, Qatar
关键词
phospholipid metabolites; choline phosphate; glycerophosphoethanolamine; choline; glycerophosphorylcholine (GPC); trimethylamine N-oxide choline; metabolomics; non-obese; insulin resistance; type 2 diabetes mellitus; TRIMETHYLAMINE-N-OXIDE; TMAO; PHOSPHATIDYLETHANOLAMINE;
D O I
10.3390/metabo14080457
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The prevalence of non-obese individuals with insulin resistance (IR) and type 2 diabetes (T2D) is increasing worldwide. This study investigates the metabolic signature of phospholipid-associated metabolites in non-obese individuals with IR and T2D, aiming to identify potential biomarkers for these metabolic disorders. The study cohort included non-obese individuals from the Qatar Biobank categorized into three groups: insulin sensitive, insulin resistant, and patients with T2D. Each group comprised 236 participants, totaling 708 individuals. Metabolomic profiling was conducted using high-resolution mass spectrometry, and statistical analyses were performed to identify metabolites associated with the progression from IS to IR and T2D. The study observed significant alterations in specific phospholipid metabolites across the IS, IR, and T2D groups. Choline phosphate, glycerophosphoethanolamine, choline, glycerophosphorylcholine (GPC), and trimethylamine N-oxide showed significant changes correlated with disease progression. A distinct metabolic signature in non-obese individuals with IR and T2D was characterized by shifts in choline metabolism, including decreased levels of choline and trimethylamine N-oxide and increased levels of phosphatidylcholines, phosphatidylethanolamines, and their degradation products. These findings suggest that alterations in choline metabolism may play a critical role in the development of glucose intolerance and insulin resistance. Targeting choline metabolism could offer potential therapeutic strategies for treating T2D. Further research is needed to validate these biomarkers and understand their functional significance in the pathogenesis of IR and T2D in non-obese populations.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Magnesium metabolism in insulin resistance, metabolic syndrome, and type 2 diabetes mellitus
    Barbagallo, Mario
    Dominguez, Ligia J.
    Brucato, Virna
    Galioto, Antonio
    Pineo, Antonella
    Ferlisi, Anna
    Tranchina, Ernesto
    Belvedere, Mario
    Putignano, Ernesto
    Costanza, Giuseppe
    NEW PERSPECTIVES IN MAGNESIUM RESEARCH: NUTRITION AND HEALTH, 2007, : 213 - +
  • [32] Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance
    Barbagallo, Mario
    Dominguez, Ligia J.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 458 (01) : 40 - 47
  • [33] Anthropometric and metabolic parameters associated with visceral fat in non-obese type 2 diabetes individuals
    Jiao, Ming
    Chen, Jiaoli
    Wang, Xiaoling
    Tao, Wenyu
    Feng, Yunhua
    Yang, Huijun
    Yang, Haiying
    Zhao, Shanshan
    Yang, Ying
    Li, Yiping
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [34] ROLE OF INSULIN RESISTANCE IN NON-OBESE ADOLESCENTS
    Baba, Reizo
    Koketsu, Masaaki
    Nagashima, Masami
    Tamakoshi, Akiko
    Inasaka, Hiroshi
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2010, 72 (3-4): : 161 - 166
  • [35] Leptin levels in non-obese and obese children and young adults with type 1 diabetes mellitus
    Verrotti, A
    Basciani, F
    Morgese, G
    Chiarelli, F
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (01) : 49 - 53
  • [36] EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus
    Obermayer, Anna
    Tripolt, Norbert J.
    Aziz, Faisal
    Hogenauer, Christoph
    Aberer, Felix
    Schreiber, Florian
    Eherer, Andreas
    Sourij, Caren
    Stadlbauer, Vanessa
    Svehlikova, Eva
    Brunner, Martina
    Goswami, Nandu
    Kojzar, Harald
    Pferschy, Peter N.
    Pieber, Thomas R.
    Sourij, Harald
    BIOMOLECULES, 2021, 11 (04)
  • [37] THE ASSOCIATION BETWEEN INSULIN RESISTANCE AND DECLINE IN ORGAN FUNCTION IN NON-OBESE JAPANESE INDIVIDUALS
    Kaneko, Kenji
    Hirota, Ryoko Shimizu
    Makino, Kanako
    Nagasaka, Tomoaki
    Kojima, Daiki
    Takaishi, Hiromasa
    Yoshino, Jun
    Itoh, Hiroshi
    JOURNAL OF HYPERTENSION, 2023, 41 : E465 - E465
  • [38] Liraglutide normalised glucose tolerance and the response of insulin to glucose in a non-obese patient with newly diagnosed type-2 diabetes mellitus
    Iizuka K.
    Niwa H.
    Takahashi Y.
    Takeda J.
    Diabetology International, 2014, 5 (4) : 254 - 259
  • [39] The effects of adiponectin and inflammatory cytokines on diabetic vascular complications in obese and non-obese patients with type 2 diabetes mellitus
    Hong, Seong Bin
    Lee, Jung Jin
    Kim, So Hun
    Suh, Young Ju
    Han, Ju Young
    Kim, Yong Seong
    Nam, Moonsuk
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 111 : 58 - 65
  • [40] Insulin resistance precipitates loss of glucose sensitivity and b-cell expansion in a non-obese model of type 2 diabetes
    Yau, D
    Asghar, Z
    Chan, F
    Le Roith, D
    Wheeler, MB
    DIABETES, 2005, 54 : A419 - A419